Skip to main navigation Skip to search Skip to main content

Germline genetic biomarker to predict metastatic risk in melanoma patients.

PrizeAcademic

Description

This project aims to develop a germline genetic biomarker to predict the metastatic potential of early-stage melanoma patients
Degree of recognitionNational
Granting OrganisationsCancer Center Amsterdam

    Fingerprint